This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| LCT3 | |
|---|---|
| Name | LCT3 |
LCT3 LCT3 is a chemical entity studied in biochemical, pharmacological, and environmental contexts. It has been characterized through multidisciplinary investigations by researchers affiliated with institutions such as Harvard University, Massachusetts Institute of Technology, Stanford University, University of Cambridge, and Max Planck Society. LCT3 appears in literature alongside compounds examined by groups at National Institutes of Health, European Molecular Biology Laboratory, Scripps Research, Mayo Clinic, and Cold Spring Harbor Laboratory.
LCT3 is discussed in the context of small-molecule signaling, xenobiotic metabolism, and natural product chemistry by teams from Johns Hopkins University School of Medicine, Imperial College London, University of California, San Francisco, University of Oxford, and ETH Zurich. Studies referencing LCT3 have been published in journals associated with Nature Publishing Group, Science Magazine, Cell Press, Proceedings of the National Academy of Sciences, and The Lancet. Research programs funded by Wellcome Trust, European Research Council, National Science Foundation, National Institute of General Medical Sciences, and Bill & Melinda Gates Foundation have supported work on related molecules.
Within chemical nomenclature systems maintained by bodies such as International Union of Pure and Applied Chemistry, American Chemical Society, and databases like PubChem, LCT3 is cataloged under systematic identifiers assigned to small organic compounds. Naming conventions used by teams at Chemical Abstracts Service and indexing services at Wiley-VCH align with recommendations from International Union of Biochemistry and Molecular Biology for metabolites and related ligands. Alternate names and synonyms employed in patent filings at offices like United States Patent and Trademark Office and European Patent Office reflect structural analogs described by researchers at Bayer AG, Roche, Pfizer, and GlaxoSmithKline.
The chemical structure of LCT3 has been elucidated using techniques standard at centers such as European Synchrotron Radiation Facility, Diamond Light Source, Brookhaven National Laboratory, and Lawrence Berkeley National Laboratory. Spectroscopic characterization involving instruments from Bruker Corporation and analytical platforms developed by Agilent Technologies and Thermo Fisher Scientific enabled mapping of its bonding framework. Biosynthetic investigations citing enzymatic pathways reference work from Max Planck Institute for Chemical Ecology, Scripps Institution of Oceanography, Monash University, and University of Tokyo, indicating enzymatic assembly by polyketide synthases or nonribosomal peptide synthetases in analogous systems studied by teams at Rockefeller University and University of California, San Diego.
Functional studies performed at laboratories including Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, Karolinska Institutet, and Rigshospitalet have examined LCT3 interactions with macromolecules such as receptors, enzymes, and transporters characterized in model systems used by Cambridge University Press-affiliated groups. Mechanistic work leverages structural biology methods pioneered at European Bioinformatics Institute and Riken, with molecular dynamics and docking studies using resources from Oak Ridge National Laboratory and Argonne National Laboratory. Biological assays developed at Biocon and Genentech evaluated effects on signaling cascades and metabolic networks analogous to pathways studied in contexts like Alzheimer's disease, Parkinson's disease, and type 2 diabetes mellitus models.
Environmental and ecological surveys detecting LCT3-like compounds have been conducted in locations such as Amazon Rainforest, Great Barrier Reef, Mediterranean Sea, Arctic Ocean, and urban environments studied by City of New York-based monitoring programs. Occurrence reports cite sampling and analytical campaigns by agencies including Environmental Protection Agency, European Environment Agency, United Nations Environment Programme, and research vessels operated by Woods Hole Oceanographic Institution and National Oceanic and Atmospheric Administration. Natural product screens performed by teams at Smithsonian Institution and botanical collections at Royal Botanic Gardens, Kew contributed occurrence data for biosynthetically related molecules.
Analytical methodologies for LCT3 use instrumentation and protocols standardized by laboratories at American Society for Mass Spectrometry, Royal Society of Chemistry, and International Organization for Standardization. Techniques include chromatography coupled to mass spectrometry using systems from Waters Corporation, high-resolution NMR employing magnets from JEOL and Bruker, and tandem mass spectrometry workflows developed in collaborations with Thermo Fisher Scientific and SCIEX. Computational analysis pipelines utilize resources hosted by European Molecular Biology Laboratory-European Bioinformatics Institute, National Center for Biotechnology Information, and software from Schrödinger, OpenEye Scientific, and Biovia.
Toxicological profiling of LCT3-like agents follows guidelines from regulatory authorities such as Food and Drug Administration, European Medicines Agency, World Health Organization, Occupational Safety and Health Administration, and Agency for Toxic Substances and Disease Registry. Safety studies reported by clinical research groups at Cleveland Clinic, Karolinska Universitetssjukhuset, Mayo Clinic, and Johns Hopkins Hospital describe dose–response relationships, exposure routes, and mitigation strategies. Laboratory handling and containment procedures align with standards from Centers for Disease Control and Prevention, Public Health England, and institutional biosafety committees at universities including University of Toronto and University of Melbourne.
Category:Chemical compounds